Lungs News and Research

RSS

Stenting not necessary in late treatment of heart attacks

Two years ago, a major study found that many patients who receive delayed treatment for a heart attack do just as well with drugs alone as they do with drugs plus stents to prop open their blocked arteries.

20 Feb 2009

Optimizing dosage of blood-thinning drug warfarin

In a large-scale study and an upcoming clinical trial, scientists supported by the National Institutes of Health address one of the trickiest issues in prescribing medicine - how to quickly optimize each patient's dosage of the common blood-thinning drug warfarin.

20 Feb 2009

Cancer death rates fall among African Americans - survival rates still low

While death rates from cancer continue to drop among African Americans, the group continues to be diagnosed at more advanced stages and have lower survival rates at each stage of diagnosis compared to whites for most cancer sites.

20 Feb 2009

Blood pressure drug losartan may benefit brain tumor patients

A widely used blood pressure medication may be the key to preventing brain function loss common after radiation treatment, according to a newly published study by researchers at Wake Forest University Baptist Medical Center.

20 Feb 2009

Experts predict 20 per cent drop in lung cancer rate

Cancer Reserach UK experts are predicting that lung cancer rates will drop by nearly a fifth over the next 20 years, according to new figures.

18 Feb 2009

Weight loss improves nonalcoholic steatohepatitis

In a recent study, Saint Louis University researchers found that weight loss of at least 9 percent helped patients reverse a type of liver disease known as nonalcoholic steatohepatitis (NASH), a finding that will allow doctors to give patients specific weight-loss goals that are likely to improve their livers.

17 Feb 2009

Hormone aldosterone linked to high blood pressure and blood vessel disease in African Americans

Researchers at The Medical College of Wisconsin in Milwaukee have linked higher levels of the hormone aldosterone to high blood pressure and blood vessel disease in African Americans.

17 Feb 2009

Doctors' resources for off-label prescribing may be incomplete, unclear

The resources doctors use to get important information about indications and reimbursement for use of cancer drugs off-label may be out-of-date and incomplete, according to a study led by researchers in the Duke Comprehensive Cancer Center.

16 Feb 2009

Closure of patent foramen ovale may benefit migraine sufferers

Reducing the frequency and severity of disabling migraines is crucial for quality of life.

16 Feb 2009

Boosting its infectivity turns benign virus into good gene therapy carrier for cystic fibrosis

Researchers from the University of California, Berkeley, and the University of Iowa have turned a relatively benign virus into a highly infectious form that is ideal as a carrier for gene therapy.

16 Feb 2009

Air pollution dangerously high around some U.S. schools

Air pollution is dangerously high around schools near some U.S. industrial plants, according to a recent study involving researchers from the University of Maryland and Johns Hopkins University.

16 Feb 2009

New approaches to prevent transplant rejection

To prevent the rejection of newly transplanted organs and cells, patients must take medicines that weaken their entire immune systems.

15 Feb 2009

Platinum-based anti-tumor compounds

Researchers in the Department of Chemistry at Wake Forest University in collaboration with colleagues at the Wake Forest University Health Sciences Comprehensive Cancer Center have developed a new class of platinum-based anti-tumor drugs that animal studies have shown to be 10 times more effective than current treatments in destroying certain types of lung cancer cells.

15 Feb 2009